CIK 0000944809 · Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 752402409
- Phone
- 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,577
- in 1 filing
Net −$24,577. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-05 | PAGANELLI JOHN A Director | Sale | −4,426 | $1.78 | $8K | 389,914 |
| 2026-11-05 | PAGANELLI JOHN A Director | Sale | −9,175 | $1.82 | $17K | 0 |
| 2026-07-24 | Logal Adam Sr. Vice President, CFO | Shares withheld for taxes | −53,266 | $1.22 | $65K | 563,396 |
| 2026-07-24 | Rubin Steven D Executive VP-Administration | Shares withheld for taxes | −53,266 | $1.22 | $65K | 6,571,966 |
| 2026-06-18 | Lachman Prem A Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2026-06-18 | MEDEL ROGER MD Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2026-06-18 | PAGANELLI JOHN A Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2026-06-18 | PFENNIGER RICHARD C JR Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2026-06-18 | UPPALURI SUBBARAO V Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2026-06-18 | Yu Alice Lin-Tsing Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2026-03-20 | PAGANELLI JOHN A Director | Purchase | +10,000 | $1.14 | $11K | 394,340 |
| 2026-03-18 | UPPALURI SUBBARAO V Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-11-21 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +102,371 | $1.30 | $133K | 216,228,819 |
| 2025-11-21 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +3,894 | $1.32 | $5K | 216,232,713 |
| 2025-11-21 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +89,375 | $1.33 | $118K | 216,322,088 |
| 2025-11-21 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +191,490 | $1.33 | $255K | 216,513,578 |
| 2025-11-21 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +192,870 | $1.34 | $257K | 216,706,448 |
| 2025-11-20 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +119,129 | $1.32 | $157K | 215,665,577 |
| 2025-11-20 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +47,105 | $1.33 | $62K | 215,712,682 |
| 2025-11-20 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +211,948 | $1.33 | $282K | 215,924,630 |
Page 1 of 8 · 159 trades